AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

911.827

-5.734-0.62%

Number of Gainers:5

Number of Losers:10

Number of Flat:17

PE:- -

High:917.856

Open:913.406

Low:907.731

Close:917.561

Volume:18.48M

Turnover:218.45M

Market Cap:235.08B

Float Cap:183.07B

Loading ...

BRIEF-Dimerix Appoints Mike Tonroe As CFO

Mesoblast (ASX:MSB) Valuation Check After FDA Backs Rexlemestrocel L’s Pain And Opioid Reduction Data

Simply Wall St.

Dimerix Appoints CFO

MT Newswires Live

Dimerix Ltd-Appointment of CFO/Company Secretary

THOMSON REUTERS

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

US Equity Investors to Focus on US-Europe Tariff Tensions, Quarterly Earnings, Inflation Data This Week

MT Newswires Live

BUZZ-Australia's Genetic Signature hits record low on lower quarterly sales

BRIEF-Nanoveu Raises A$7.5 Million Via Placement At A$0.088 Per Share

BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal

BRIEF-Genetic Signatures Logs Q2 Sales Of A$3.3 Million

BUZZ-Australia's Atomo Diagnostics jumps on new liver test license

BUZZ-Australia's Nanoveu falls on discounted placement

Nanoveu Ltd - Raises a$7.5 Mln via Placement at a$0.088 per Share

THOMSON REUTERS

Atomo Diagnostics - Agreement With Burnet Diagnostics Initiative

THOMSON REUTERS

Atomo Diagnostics - Exclusive Licence for a Novel Liver Function Test on Pascal

THOMSON REUTERS

Genetic Signatures Ltd - Q2 Sales of a$3.3 Million

THOMSON REUTERS

Do Shifting Analyst Views On American Tower’s (AMT) Growth Reset Its Core Investment Narrative?

Simply Wall St.

NZX Midday Sector Update: Industrial Services Shares Rise, Health Technology Sector Falls

MT Newswires Live

BRIEF-Mesoblast Says FDA Acknowledges Effects On Pain Intensity Favor Rexlemestrocel-L

Mesoblast Advances Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain Following FDA Support

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":911.82684,"timestamp":1768971599995,"preClose":917.56067,"halted":0,"volume":18475561,"delay":0,"changeRate":-0.006249,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-5.733826,"latestTime":"01-21 16:00:00 AEDT","open":913.4064,"high":917.85645,"low":907.7311,"amount":218446268,"amplitude":0.011035,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1769036400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1768950000000,1768971600000]],"turnoverRate":0.001289,"increases":5,"decrements":14,"flats":13,"marketCap":235079212101,"floatMarketCap":183065288242.46094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":917.85645,"amplitude":0.011035,"preClose":917.56067,"low":907.7311,"latestPrice":911.82684,"volume":18475561,"delay":0,"open":913.4064,"prevYearClose":900.1661,"prevWeekClose":915.637,"prevMonthClose":900.166,"prevQuarterClose":900.166,"fiveDayClose":906.968,"twentyDayClose":906.068,"sixtyDayClose":985.188,"secType":"PLATE","market":"AU","turnoverRate":0.001289,"marketCap":235079212101,"floatMarketCap":183065288242.46094,"timestamp":1768971599995,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":5,"down":10,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605125721","title":"BRIEF-Dimerix Appoints Mike Tonroe As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2605125721","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605125721?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:37","pubTimestamp":1768959451,"startTime":"0","endTime":"0","summary":"BRIEF-Dimerix Appoints Mike Tonroe As CFOJan 21 (Reuters) - Dimerix Ltd DXB.AX:APPOINTMENT OF CFO/COMPANY SECRETARYAPPOINTS MIKE TONROE AS CFOFurther company coverage: DXB.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUE8GHV2F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","DXB.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2605608122","title":"Mesoblast (ASX:MSB) Valuation Check After FDA Backs Rexlemestrocel L’s Pain And Opioid Reduction Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2605608122","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605608122?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:47","pubTimestamp":1768956470,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) is back in focus after feedback from the U.S. FDA on its rexlemestrocel L cell therapy, which targets chronic discogenic low back pain and is directly linked to opioid use reduction.\nSee our latest analysis for Mesoblast.\nDespite the positive FDA feedback, Mesoblast’s recent share price momentum has been soft, with a 7 day share price return of a 7.0% decline and a 30 day share price return of a 12.7% decline, while the 3 year total shareholder return of 177.6% points to a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-after-fda-backs-rexlemestro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-after-fda-backs-rexlemestro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK7508","MSB","BK7067","MSB.AU","BK7501","BK4006"],"gpt_icon":0},{"id":"2605114264","title":"Dimerix Appoints CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2605114264","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605114264?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:24","pubTimestamp":1768947849,"startTime":"0","endTime":"0","summary":"Dimerix (ASX:DXB) appointed Mike Tonroe as chief financial officer, effective Jan. 29, according to a Wednesday filing with the Australian bourse.Tonroe brings over 30 years of experience, having most recently served as the CFO of Imugene (ASX:IMU), the filing added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","DXB.AU","IMU.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2605415141","title":"Dimerix Ltd-Appointment of CFO/Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2605415141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605415141?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:28","pubTimestamp":1768944510,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUE8GHV2F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7067","DXB.AU"],"gpt_icon":0},{"id":"2605110440","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605110440?lang=en_us&edition=fundamental","pubTime":"2026-01-21 01:08","pubTimestamp":1768928883,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsAdds details on Roche, Abbvie and CSL. Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL1OM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035775433.USD","LU1880407132.USD","LU2112291526.USD","LU2361044949.HKD","LU1868836757.USD","BK4592","LU2168564149.EUR","LU2091194634.USD","LU2133065610.SGD","LU0889566641.SGD","LU1674673691.USD","LU0203345920.USD","LU1061106388.HKD","SG9999001176.USD","BK4534","LU1244550494.USD","LU0820561909.HKD","IE00B1BXHZ80.USD","SG9999003800.SGD","IE00B3PB1722.GBP","LU1941712264.USD","LU2471134879.HKD","IE00BJJMRY28.SGD","NVS","LU0289961442.SGD","LU1868837136.USD","LU2750360997.AUD","LU2324357040.USD","LU2168564495.EUR","LU0128525689.USD","BK4533","03165","LU1983299246.USD","LU1221951129.SGD","LU0170899867.USD","LU0889565080.SGD","LU0289739343.SGD","LU1084165304.USD","LU1880407215.USD","LU2264538146.SGD","LU0972486137.USD","LU0472753341.HKD","LU0708995401.HKD","LU0960981461.USD","LU1814569148.SGD","CSL.AU","IE00B775H168.HKD","IE0005OL40V9.USD","LU2471134796.USD","LU0912757837.SGD","LU1804176565.USD","LU0526926950.USD","LU0345770308.USD","LU2129689605.HKD","LU0306807586.USD","IE00BKPKM643.USD","LU0353189763.USD","LU0499090636.EUR","LU0323591593.USD","LU0963555726.SGD","IE00BJT1NW94.SGD","JNJ","LU0211328371.USD","LU0949170772.SGD","LU2746668974.SGD","LU0354030438.USD","LU0211331839.USD","SG9999015945.SGD","LU0310800965.SGD","LU0557290698.USD","SG9999014914.USD","LU0316494557.USD","LU1267930490.SGD","LU1019632923.USD","LU0266013472.USD","LU2471134523.USD","LU0511384066.AUD","LU1232071149.USD","IE0004445239.USD","LU1868837300.USD","LU0122379950.USD","LU0784385170.HKD","LU1153585028.USD","LU1585245621.USD","BK7511","LU2168564222.USD","LU0225284248.USD","ABBV","LU1551013342.USD","IE00B1XK9C88.USD","LU2089283258.USD","LU1548497426.USD","LU1551013425.SGD","LU1674673428.USD","LU0889565916.HKD","LU1119994496.HKD","LU0471298777.SGD","BK4007","IE0004445015.USD","LU1116320737.USD","LU0757432116.USD","LU0868494617.USD","LU0471298694.HKD","IE00BGHQF631.EUR","AMGN","IE00B19Z9P08.USD","AZN","BK4504","LU0011850046.USD","LU0203347892.USD","LU0070302665.USD","SG9999015986.USD","LU0320765489.SGD","SG9999015952.SGD","LU2552382215.SGD","LU1989772840.SGD","LU0225283273.USD","LU2114397693.USD","LU0225771236.USD","LU0096364046.USD","LU1366192091.USD","LU0029864427.USD","LU0130517989.USD","LU1035773651.USD","LU2211815571.USD","LU2125154778.USD","LU1244550221.USD","LU1914381329.SGD","LU0792757196.USD","LU2237443382.USD","PFE","LU2106854487.HKD","LU0784384876.USD","LU0827474353.SGD","LU0786609619.USD","LU0823434740.USD","LU2237443549.SGD","LU0920783379.SGD","LU0787776722.HKD","IE00BN29S564.USD","LU2293690082.USD","LU0964806797.USD","SG9999017495.SGD","LU0882574139.USD","BIIB","SGXZ99366536.SGD","LU1883839398.USD","SGXZ31699556.SGD","LU1064927863.SGD","LU2265009873.SGD","LU0477156953.USD","LU2602419157.SGD","IE00BK4W5M84.HKD","LU0256863902.USD","LU1496350171.SGD","IE00BBT3K403.USD","LU1934455277.USD","LU1868836914.USD","LU2505996509.AUD","LU2237443465.HKD","LU1066051498.USD","LU0198837287.USD","LU1917777945.USD","BK7501","LU1280957306.USD","LU0965508806.USD","LU0784383803.USD","LU1127390331.HKD","BK4588","LU2491050071.SGD","LU2471134952.CNY","SG9999002224.SGD","LU0672654240.SGD","LU2552382058.USD","IE00BVYPNV92.GBP","SG9999015341.SGD","LU1323610961.USD","LU2430703095.HKD","LU1116320901.HKD","IE00B4JS1V06.HKD","LU1941712348.USD","LU2108987350.USD","LU0795875086.SGD","LU1301847155.USD","BK4566","LU1839511570.USD","BK4583","LU2236285917.USD","LU0077335932.USD","LU0784385840.USD","LU1032466523.USD","SGXZ81514606.USD","LU1051770623.HKD","LU0920840948.USD","LU0969580561.USD","LU1069344957.HKD","LU0345770993.USD","LU0823434583.USD","LU2430703178.SGD","LU1506573853.SGD","LU0052756011.USD","LU0353189680.USD","GILD","LU1720051017.SGD","LU1778281490.HKD","SG9999014880.SGD","LU1718418525.SGD","LU0354030511.USD","SG9999014542.SGD","LU0496365809.HKD","LU0683600562.USD","LU0861579265.USD","LU1571399168.USD","LU1934455863.HKD","LU0124676726.USD","LU1496350502.SGD","IE000M9KFDE8.USD","LU2456880835.USD","LU0070217475.USD","LU1481600234.SGD","LU2462157665.USD","LU1003076772.USD","IE00BSNM7G36.USD","LU0208291251.USD","LU1894683348.USD","LU0965509101.SGD","LU2461242641.AUD","LU0320765992.SGD","LU2491050154.USD","LU2746668461.USD","LU0689472784.USD","LU0047473722.EUR","LU0949170426.SGD","LU1935042991.SGD","LU2087625088.SGD","IE00B2B36J28.USD","LU0047473722.SGD","LU1162221912.USD","LU1974910355.USD","IE00BJJMRX11.SGD","LU1170363599.USD","LU0106261372.USD","LU0640478417.SGD","LU0823399737.USD","IE00B3T34201.USD","LU0320765059.SGD","LU0211326755.USD","IE00B7KXQ091.USD","LU0640476718.USD","LU0545039389.USD","RHHBY","LU1093756168.USD","LU0128525929.USD","IE00BKVL7J92.USD","BK5011","LU0097036916.USD","LU1066053197.SGD","LU0171293334.USD","LU0345777147.USD","LU0158827948.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1720051108.HKD","SG9999002232.USD","IE00BFXG1179.USD","SG9999014898.SGD","IE00BKDWB100.SGD","IE00BVYPNW00.USD","IE00B894F039.SGD","LU0058720904.USD","LU0234572021.USD","BK4139","LU1261432733.SGD","IE0002141913.USD","LU2417539215.USD","LU1201861249.SGD","LU0310799852.SGD","SG9999001176.SGD","SG9999018865.SGD","LU2125154935.USD","IE00BJJMRZ35.SGD","SGXZ51526630.SGD","IE00BK4W5L77.USD","LU0109394709.USD","LU0385154629.USD","LU2468319806.SGD","SG9999014567.USD","BK4599","LU2505996681.GBP","SG9999013999.USD","LU2023251221.USD","LU2592432038.USD","IE00B7SZLL34.SGD","LU2293690249.USD","IE0034235303.USD","LU0321505439.SGD","LU0857590862.USD","LU0211326839.USD","LU0057025933.USD","LU1196500208.SGD","LU2491049909.HKD","LU0882574055.USD","LU1929549753.HKD","LU0265550359.USD","LU0234570918.USD","LU0965509283.SGD","IE00BDGV0183.EUR","SG9999014575.USD","LU1267930730.SGD","LU0985320562.USD","LU1894683264.USD","IE00BKPKM429.USD","LU1989771016.USD","LU1712237335.SGD","LU1023059063.AUD","LU2089984988.USD","LU0738911758.USD","LU2237443622.USD","IE00B19Z9Z06.USD","LU1093756325.SGD","LU1037948897.HKD","LU0238689110.USD","IE00BJLML261.HKD","LU1868836591.USD","BK7508","BK4568","LU0943347566.SGD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4516","LU2023250504.SGD","LU0203202063.USD","LU2750360641.GBP","LU0997586432.USD","LU0456855351.SGD","LU2168564065.EUR","LU0094547139.USD","LU1104425308.USD","LU1153584641.USD","LU0306806265.USD","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","LU2168563687.JPY","LU0109391861.USD","LU0708994859.HKD","04332","LU2129689431.USD","LU0310800379.SGD","SG9999015358.SGD","LU1430594728.SGD","LU1064131342.USD","BK4532","LU1019634622.SGD","BK4559","LU1059921491.USD","IE00BLSP4452.SGD","SNY","IE00BN8TJ469.HKD","IE0034235188.USD","LU1487256676.USD","LU2242652126.USD","LU0965509010.AUD","LU1015430645.USD","LU0648001328.SGD","SG9999014906.USD","LU0957799991.USD","LU2089284900.SGD","LU0980610538.SGD","SG9999014559.SGD","LU0203201768.USD","LU0820561818.USD","LU1291159041.SGD","LU0130102774.USD","LU2357305700.SGD","LU2430703251.USD","LU1003077747.HKD","LU2360106947.USD","LU0661504455.SGD","LU2347655156.SGD","SG9999015978.USD","LU1481599808.USD","LU0006306889.USD","SG9999011175.SGD","IE00BFSS7M15.SGD","LU0976567544.SGD","LU1934455194.USD","LU2360032135.SGD","LU0575583348.USD","LU2237438978.USD","LU0265550946.USD","LU0345769631.USD","LU1267930573.SGD","LU1623119135.USD","IE00B4R5TH58.HKD","LLY","IE0002270589.USD","IE00B42XCP33.USD","LU0417517546.SGD","LU0256863811.USD","LU1267930813.SGD","LU2539964713.USD","LU1989772923.USD","LU1057294990.SGD","LU2361044865.SGD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU1988902786.USD","LU2361045086.USD","BK4578","BK4581","LU0553294199.USD","LU0689626769.HKD","LU1074936037.SGD","LU2552382132.HKD","LU0061475181.USD","LU0345777659.USD","LU1699723380.USD","LU1244550577.SGD","LU2237443978.SGD","IE00BLSP4239.USD","LU1732799900.SGD","LU0466842654.USD","LU1032955483.USD","LU2237443895.HKD","IE0009355771.USD","LU1066051225.USD","LU2063271972.USD","LU0211327993.USD","LU1078025761.USD","LU2242646821.SGD","LU0795875169.SGD","LU1267930227.SGD","LU0114720955.EUR","LU0345769128.USD","LU2087621335.USD","BK4585","SG9999001440.SGD","BK4550","LU0320765646.SGD","SG9999018857.SGD","LU2279689827.SGD","LU0432979614.USD","LU0079474960.USD","BK7067","IE00BWXC8680.SGD","LU0098860793.USD","LU0985481810.HKD","IE00B19Z3581.USD","LU2023250843.SGD","LU0069063385.USD","LU1732800096.USD","LU1037948541.HKD","LU2129689514.USD","LU1221951046.USD","LU1069347547.HKD","MRK","LU0823416689.USD","LU1066051811.HKD"],"gpt_icon":1},{"id":"2604192926","title":"US Equity Investors to Focus on US-Europe Tariff Tensions, Quarterly Earnings, Inflation Data This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2604192926","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604192926?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:26","pubTimestamp":1768908419,"startTime":"0","endTime":"0","summary":"US equity investors will focus on growing tensions between the Trump administration and its European allies over Greenland, the Federal Reserve's preferred inflation data, and earnings this week.* Pre","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ99366536.SGD","LU2552382215.SGD","BK4551","LU1814569148.SGD","LU0256863811.USD","PSQ","BK4585","BK4548","LU1668664300.SGD","NQmain","QQQJ","SQQQ","LU0081259029.USD","TSYW.SI","LU0787776722.HKD","LU1046421795.USD","LU0106261372.USD","LU0127658192.USD","IE00B19Z8X17.USD","LU2896262040.SGD","MMM","SPDN","LU0096364046.USD","DOG","DIA","BK4504","LU2326559502.SGD","HIBL","IVV","SPXS","BK4141","MYMmain","LU1127390331.HKD","NFLX","BK4587","IE0002270589.USD","LU1363072403.SGD","BK4535","IE00BZ1G4Q59.USD","LU0251142724.SGD","BK7049","LU1791807156.HKD","SG9999002224.SGD","USJW.SI","IVW","LU0353189680.USD","SDOW","SCHW","LU1035775433.USD","LU1778281490.HKD","LU0321505868.SGD","QYLG","QQQM","SPY","LU0868494708.USD","BK4512","BK4206","LU2087625088.SGD","LU2362540622.SGD","BK4554","LU0130517989.USD","LU0109391861.USD","LU1823568750.SGD","LU0225283273.USD","VTI","MNQmain","IE00BQXX3C00.GBP","LU1674673428.USD","IE00B19Z8W00.USD","LU1868836591.USD","LU1069344957.HKD","IE00BQXX3D17.EUR","LU1069347547.HKD","BK4588","LU0256863902.USD","BK4207","LU2543165471.USD","LU0203201768.USD","IE00B19Z9505.USD","LU1989764664.SGD","LU0029864427.USD","LU1267930730.SGD","LU0708995401.HKD","QYLD","LU1267930573.SGD","QQQY","LU0170899867.USD","SPXU","LU0345774391.USD","LU0006306889.USD","SPLV","LU0708994859.HKD","VOO","SGXZ51526630.SGD","TQQQ","BK4527","BMAY","LU2089985449.USD","VOOV","SG9999001077.SGD","QID","LU2361045086.USD","LU1093756168.USD","SG9999014021.USD","LU0980610538.SGD","DXD","BK4108","LU2931357623.SGD","BK4211","QLD","BK4008","BK4579","LU1366192091.USD","LU0942090050.USD","QQQE","LU0742534661.SGD","LU0210533765.USD","LU0786609619.USD","LU2362541273.HKD","LU0320765059.SGD","LU2361044865.SGD","LU1232071149.USD","LU0321505439.SGD","LU0274383776.USD","LU0640476718.USD","LU1868836914.USD","BK4515","BK4589","IE00B19Z3581.USD","LU0011850046.USD","LU1093756325.SGD","LU1868837300.USD","LU2108987350.USD","NVIW.SI","BK4127","LU0215105999.USD","LU1988902786.USD","SGXZ23171101.USD","LU0719512351.SGD","LU2461242641.AUD","LU0672654240.SGD","LU2237957902.USD","LU1720051108.HKD","LU1674673691.USD","LU2148611432.USD","SSO","LU0130102774.USD","LU1861220207.SGD","LU0345774631.USD","LU2552382132.HKD","UDOW","LU2860962120.EUR","BK4215","LU0251131958.USD","LU1316542783.SGD","LU0234572021.USD","LU1720051017.SGD","LU0882574139.USD","USAW.SI","LU1201861249.SGD","IE00B7SZLL34.SGD","XDTE","LU2264538146.SGD","LU1861217088.USD","BK4575","INTC","IE00BKVL7J92.USD","SG9999004303.SGD","SG9999014039.USD","LU0648001328.SGD","LU2552382058.USD","BK4533","BK4524","LU0971096721.USD","DDM","LU1548497426.USD","BK4543","BK4566","GPIX","IE000M9KFDE8.USD","LU1035773651.USD","IE00B19Z3B42.SGD","GPIQ","UAL","LU0128525929.USD","04335","LU1435385759.SGD","LU0642271901.SGD","SGXZ81514606.USD","LU2360107671.USD","SG9999002232.USD","LU0203202063.USD","LU1868836757.USD","LU0079474960.USD","LU0234570918.USD","USB","LU2237438978.USD","LU0048573561.USD","LU1074936037.SGD","BK4581","LU0868494617.USD","SH","LU1280957306.USD","SPYM","SG9999014005.SGD","LU0353189763.USD","BK4605","LU0077335932.USD","LU0683600562.USD","SDS","BK4532","LU1868837136.USD","LU2361044949.HKD","LU2237957811.SGD","SPMO","SG9999014013.SGD","JEPQ","BK4602","LU0061475181.USD","LU0477156953.USD","LU0106831901.USD","LU2362541513.USD","DJX","BK4534","IE00BQXX3F31.USD","BK4612","BK4559","BK4529","LU0266013472.USD","LU1894683264.USD","LU2357305700.SGD","BK4550","BK4598","IE00BFXG1179.USD","LU0097036916.USD","LU0210536198.USD","LU0417517546.SGD","LU1064131342.USD","BK7501","LU1153585028.USD","BK4500","LU1894683348.USD","IVOO","LU0310800379.SGD","LU1429558221.USD","IE00BKPKM429.USD","BK4507","SPXL","SPYV","LU0082616367.USD","BK7040"],"gpt_icon":1},{"id":"2604166909","title":"BUZZ-Australia's Genetic Signature hits record low on lower quarterly sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2604166909","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604166909?lang=en_us&edition=fundamental","pubTime":"2026-01-20 12:55","pubTimestamp":1768884937,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signature hits record low on lower quarterly sales** Shares of Genetic Signatures GSS.AX down as much as 4.6% at its record low level of A$0.21** The molecular diagnostics firm posts Q2 FY26, sales of A$3.3 million , down from A$3.8 million a year ago** About 422,306 shares change hands, 3.7x 30-day average       ** Stock fell 60.3% in 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL0B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2604152587","title":"BRIEF-Nanoveu Raises A$7.5 Million Via Placement At A$0.088 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2604152587","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604152587?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:17","pubTimestamp":1768871824,"startTime":"0","endTime":"0","summary":"BRIEF-Nanoveu Raises A$7.5 Million Via Placement At A$0.088 Per ShareJan 20 (Reuters) - Nanoveu Ltd NVU.AX:RAISES A$7.5 MILLION VIA PLACEMENT AT A$0.088 PER SHAREFurther company coverage: NVU.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK09P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVU.AU","BK7501","BK7076"],"gpt_icon":0},{"id":"2604302152","title":"BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal","url":"https://stock-news.laohu8.com/highlight/detail?id=2604302152","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604302152?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:15","pubTimestamp":1768871707,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On PascalJan 20  - Atomo Diagnostics Ltd AT1.AX:EXCLUSIVE LICENCE FOR A NOVEL LIVER FUNCTION TEST ON PASCALAGREEMENT WITH BURNET DIAGNOSTICS INITIATIVEFurther company coverage: AT1.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7501","AT1.AU"],"gpt_icon":0},{"id":"2604415424","title":"BRIEF-Genetic Signatures Logs Q2 Sales Of A$3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2604415424","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604415424?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:06","pubTimestamp":1768871199,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Logs Q2 Sales Of A$3.3 MillionJan 20 (Reuters) - Genetic Signatures Ltd GSS.AX:Q2 SALES OF A$3.3 MILLIONFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK0KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048"],"gpt_icon":0},{"id":"2604154385","title":"BUZZ-Australia's Atomo Diagnostics jumps on new liver test license","url":"https://stock-news.laohu8.com/highlight/detail?id=2604154385","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604154385?lang=en_us&edition=fundamental","pubTime":"2026-01-20 08:40","pubTimestamp":1768869631,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Atomo Diagnostics jumps on new liver test license** Atomo Diagnostics AT1.AX jumps 11.4% to A$0.039; set for strongest trading session since December 9, 2025** Medical devices co signs exclusive global licensing agreement with Burnet Diagnostics Initiative for novel liver function test** Says license for Burnet's liver function test supports commercialisation of rapid test for immediate detection of liver injury** Test can be administered via co's self-testing device Pascal cassette** YTD, AT1 up 5.6%; had risen 89.5% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL6N3YL01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AT1.AU","BK7007","BK7501"],"gpt_icon":0},{"id":"2604964151","title":"BUZZ-Australia's Nanoveu falls on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2604964151","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604964151?lang=en_us&edition=fundamental","pubTime":"2026-01-20 08:22","pubTimestamp":1768868553,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Nanoveu falls on discounted placement** Shares of Nanoveu NVU.AX fall 4.1% to A$0.093, on track for worst day since December 10 if current losses hold** Advanced nanotechnology firm t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL00K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7076","BK7501","NVU.AU"],"gpt_icon":0},{"id":"2604967156","title":"Nanoveu Ltd - Raises a$7.5 Mln via Placement at a$0.088 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2604967156","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604967156?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:50","pubTimestamp":1768863035,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK09P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVU.AU","BK7501","BK7076"],"gpt_icon":0},{"id":"2604568961","title":"Atomo Diagnostics - Agreement With Burnet Diagnostics Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2604568961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604568961?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:31","pubTimestamp":1768861901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7007","BK7501"],"gpt_icon":0},{"id":"2604156893","title":"Atomo Diagnostics - Exclusive Licence for a Novel Liver Function Test on Pascal","url":"https://stock-news.laohu8.com/highlight/detail?id=2604156893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604156893?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:31","pubTimestamp":1768861901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2604153090","title":"Genetic Signatures Ltd - Q2 Sales of a$3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2604153090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604153090?lang=en_us&edition=fundamental","pubTime":"2026-01-20 05:21","pubTimestamp":1768857686,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2604879132","title":"Do Shifting Analyst Views On American Tower’s (AMT) Growth Reset Its Core Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2604879132","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604879132?lang=en_us&edition=fundamental","pubTime":"2026-01-19 21:10","pubTimestamp":1768828232,"startTime":"0","endTime":"0","summary":"In recent days, American Tower has been the focus of multiple analyst revisions that reassessed its growth outlook amid mixed macroeconomic conditions and evolving tower-leasing expectations ahead of its upcoming earnings report. \nWhile some analysts highlighted sector-specific risks such as lower leasing tied to EchoStar and comparisons with fixed income, they also pointed to improving supply-demand fundamentals and ongoing expectations for earnings and revenue growth, underscoring how...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/do-shifting-analyst-views-on-american-towers-amt-growth-rese","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/do-shifting-analyst-views-on-american-towers-amt-growth-rese","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4084","AMT.AU","BK4585","BK4588","BK7007","BK7501","AMT","BK4219","BK4554","BK4534","BK4581"],"gpt_icon":0},{"id":"2604903641","title":"NZX Midday Sector Update: Industrial Services Shares Rise, Health Technology Sector Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2604903641","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604903641?lang=en_us&edition=fundamental","pubTime":"2026-01-19 09:00","pubTimestamp":1768784429,"startTime":"0","endTime":"0","summary":"Industrial services shares gained the most on New Zealand's Exchange, rising nearly 3% by midday Monday.Shares of Ventia Services Group  rose roughly 3% in recent trade.Meanwhile, the health technology sector fell 2%.Shares of Fisher & Paykel Healthcare  were down past 2% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK8004","NZ20C.NZ","T10G.NZ","FPH.AU","NZX.NZ","BK7501","BK7007","FPH.NZ","VNT.AU","BK7055","BK8020","NZ50G.NZ"],"gpt_icon":0},{"id":"2604908825","title":"BRIEF-Mesoblast Says FDA Acknowledges Effects On Pain Intensity Favor Rexlemestrocel-L","url":"https://stock-news.laohu8.com/highlight/detail?id=2604908825","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604908825?lang=en_us&edition=fundamental","pubTime":"2026-01-19 08:04","pubTimestamp":1768781085,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Says FDA Acknowledges Effects On Pain Intensity Favor Rexlemestrocel-LJan 18 (Reuters) - Mesoblast Ltd MSB.AX:FDA ACKNOWLEDGES EFFECTS ON PAIN INTENSITY FAVOR REXLEMESTROCEL-L, CONFIRM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nTUA6Y1RZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK4139","BK7501","MSB.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2604397003","title":"Mesoblast Advances Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain Following FDA Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2604397003","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604397003?lang=en_us&edition=fundamental","pubTime":"2026-01-19 08:01","pubTimestamp":1768780900,"startTime":"0","endTime":"0","summary":"Mesoblast Limited has announced feedback from the U.S. Food & Drug Administration  regarding its allogeneic cell therapy product, rexlemestrocel-L, for patients with chronic discogenic low back pain . The FDA acknowledged that effects on pain intensity favor rexlemestrocel-L based on data from the company's first randomized controlled Phase 3 trial , with a clinically meaningful reduction in pain intensity at 12 months supporting product efficacy. The FDA also indicated that results on opioid reduction from at least one adequate and well-controlled trial could be included in the Clinical Studies section of the product labeling. A second randomized controlled Phase 3 trial  is currently recruiting in the United States and is expected to complete enrollment in the coming months. Results from the first Phase 3 trial have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nNDLc5yjjf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B3QW5Z07.USD","BK7067","SG9999014021.USD","BK7501","BK7508","IE00BKPKM429.USD","BK4585","BK4588","MSB.AU","SG9999014013.SGD","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","SG9999014039.USD","IE00B64PRP62.GBP","LU2210150020.SGD","LU2095319765.USD","BK4112","SG9999014005.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":88,"code":"91000000","status":"200"}]}}